N-[(5Z,8Z,11Z)-14,15-epoxyicosatrienoyl]ethanolamine

Term ID

CHEBI:136991

Synonyms

(5Z,8Z,11Z)-N-(2-hydroxyethyl)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienamide
14(15)-EET-EA
14,15-EET-EA
14,15-epoxy-5,8,11-icosatrienoic acid ethanolamide
N-(14,15-epoxy-5Z,8Z,11Z-eicosatrienoyl)-ethanolamine
N-(14,15-epoxy-5Z,8Z,11Z-icosatrienoyl)ethanolamine
N-[(5Z,8Z,11Z)-14,15-epoxyicosatrienoyl]ethanolamine

Definition

An N-(polyunsaturated fatty acyl)ethanolamine obtained by formal epoxidation across the 14,15-double bond of anandamide.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: endocannabinoid epoxide N-(long-chain-acyl)ethanolamine N-(polyunsaturated fatty acyl)ethanolamine oxidized N-(fatty acyl)-ethanolamine

endocannabinoid epoxide N-(long-chain-acyl)ethanolamine N-(polyunsaturated fatty acyl)ethanolamine oxidized N-(fatty acyl)-ethanolamine Show first 5 Terms
has_functional_parent: 14,15-EET anandamide

14,15-EET anandamide Show first 5 Terms
has_role: human xenobiotic metabolite

human xenobiotic metabolite Show first 5 Terms

Phenotype

Phenotype resulting from N-[(5Z,8Z,11Z)-14,15-epoxyicosatrienoyl]ethanolamine

Phenotype where environments contain N-[(5Z,8Z,11Z)-14,15-epoxyicosatrienoyl]ethanolamine

Phenotype modified by environments containing N-[(5Z,8Z,11Z)-14,15-epoxyicosatrienoyl]ethanolamine

Human Disease Model